To explore the limitations of BMI in prognostication and the potential benefits of incorporating frailty and central adiposity measures in critical care settings.
Approach:
BMI Overview: BMI is a widely used measure of body size but has limited prognostic value at the individual level, particularly in relation to mortality.
Frailty Assessment: Frailty is assessed using the Clinical Frailty Scale (CFS), which measures functional status and biological vulnerability, and is associated with poorer outcomes in critical illness.
Combining Measures: Combining BMI, frailty, and waist-to-height ratio may enhance prognostication and outcome prediction in critical illness.
Key Findings:
BMI shows a J-shaped association with mortality, but its individual prognostic value is limited.
Frailty is a multidimensional syndrome that correlates with poorer outcomes in critical illness.
Patients with sarcopenic obesity represent a high-risk group with higher disease burden and poorer outcomes.
Interpretation:
The relationship between BMI, frailty, and mortality in critical illness is complex and requires careful consideration for better risk stratification.
Limitations:
Potential measurement errors in BMI and frailty assessments.
Variations in body composition and missing data.
Limited follow-up in some patients.
Conclusion:
A multidimensional risk assessment incorporating frailty and functional reserve may improve prognostic precision in critical care.
